Ce. Ahlfors et al., PLASMA FLUORESCEIN BINDING AND TRANSCAPILLARY FLUORESCEIN ESCAPE RATEIN RENAL-FAILURE ASSOCIATED WITH DIABETES, American journal of kidney diseases, 25(4), 1995, pp. 543-547
Microvascular damage, often resulting in renal failure, is a common co
mplication of diabetes. Transcapillary fluorescein escape rate (TCFER)
as monitored by intravital microscopy has been used as an indicator o
f the extent of capillary damage in diabetes and to assess improvement
in microvascular function after combined kidney-pancreas transplant.
However, fluorescein anion binds to plasma albumin, and albumin-ligand
binding may be altered in the presence of renal disease. The purpose
of this study was to compare fluorescein binding by plasma from diabet
ics with renal failure with plasma from healthy nondiabetics. Fluoresc
ein binding by plasma from seven type I diabetics awaiting kidney-panc
reas transplant and seven healthy adults of similar age and sex was st
udied using ultrafiltration and dialysis. There was no significant dif
ference in the apparent albumin binding of fluorescein at physiologica
lly relevant fluorescein concentrations, even though the TCFER was sig
nificantly increased in the diabetics as compared with the controls. H
ippurate, a ligand that accumulates in renal failure, did alter fluore
scein binding in a defatted albumin solution but not sufficiently to a
ccount for the differences in TCFERs. These data indicate that impaire
d albumin binding of fluorescein does not contribute significantly to
the TCFER in diabetics with renal failure. (C) 1995 by the National Ki
dney Foundation, Inc.